Towards Improved Cancer Diagnosis and Prognosis Using Analysis of Gene Expression Data and Computer Aided Imaging
暂无分享,去创建一个
Gabriela Alexe | Gyan Bhanot | Anant Madabhushi | Ajay Basavanhally | Scott Doyle | Shridar Ganesan | Michael Seiler | Anupama Reddy | G. Bhanot | A. Madabhushi | Anupama Reddy | G. Alexe | S. Ganesan | Scott Doyle | M. Seiler | Ajay Basavanhally | J. Monaco | James Monaco
[1] Yoav Freund,et al. Experiments with a New Boosting Algorithm , 1996, ICML.
[2] George Lee,et al. An Empirical Comparison of Dimensionality Reduction Methods for Classifying Gene and Protein Expression Datasets , 2007, ISBRA.
[3] C. DeLisi,et al. Data Perturbation Independent Diagnosis and Validation of Breast Cancer Subtypes Using Clustering and Patterns , 2006, Cancer informatics.
[4] Debajit K. Biswas,et al. NF-κB activation in human breast cancer specimens and its role in cell proliferation and apoptosis , 2004 .
[5] S. Bailey,et al. Nuclear factor-κB activation: a molecular therapeutic target for estrogen receptor–negative and epidermal growth factor receptor family receptor–positive human breast cancer , 2007, Molecular Cancer Therapeutics.
[6] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[7] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[8] M. Sheaff,et al. The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators. , 2003, Surgery.
[9] Andrew Zisserman,et al. A Statistical Approach to Texture Classification from Single Images , 2004, International Journal of Computer Vision.
[10] E. Winer,et al. Predictors of Resistance to Preoperative Trastuzumab and Vinorelbine for HER2-Positive Early Breast Cancer , 2007, Clinical Cancer Research.
[11] Jill P. Mesirov,et al. Consensus Clustering: A Resampling-Based Method for Class Discovery and Visualization of Gene Expression Microarray Data , 2003, Machine Learning.
[12] A. Nobel,et al. Concordance among Gene-Expression – Based Predictors for Breast Cancer , 2011 .
[13] Adrian E. Raftery,et al. Model-Based Clustering, Discriminant Analysis, and Density Estimation , 2002 .
[14] Z. Trajanoski,et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. , 2005, The New England journal of medicine.
[15] Peter L. Hammer,et al. Spanned patterns for the logical analysis of data , 2006, Discret. Appl. Math..
[16] George Coukos,et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. , 2003, The New England journal of medicine.
[17] Shridar Ganesan,et al. X chromosomal abnormalities in basal-like human breast cancer. , 2006, Cancer cell.
[18] S. Hilsenbeck,et al. Neoadjuvant trastuzumab induces apoptosis in primary breast cancers , 2005, Nature Clinical Practice Oncology.
[19] S. Ménard,et al. Macrophage infiltrate and prognosis in c-erbB-2-overexpressing breast carcinomas. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] Vipin Kumar,et al. Multilevel Graph Partitioning Schemes , 1995, ICPP.
[21] Yudong D. He,et al. A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .
[22] Student,et al. THE PROBABLE ERROR OF A MEAN , 1908 .
[23] Luis Mateus Rocha,et al. Singular value decomposition and principal component analysis , 2003 .
[24] D. Rubin,et al. Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper , 1977 .
[25] G. Dranoff. The Therapeutic Implications of Intratumoral Regulatory T Cells , 2005, Clinical Cancer Research.
[26] S. Bailey,et al. Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer. , 2007, Molecular cancer therapeutics.
[27] Joydeep Ghosh,et al. Cluster Ensembles --- A Knowledge Reuse Framework for Combining Multiple Partitions , 2002, J. Mach. Learn. Res..
[28] Wolfgang Heller,et al. Triple-negative breast cancer: therapeutic options. , 2007, The Lancet. Oncology.
[29] L. Happerfield,et al. Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast. , 1996, British Journal of Cancer.
[30] Yi Zhang,et al. Entropy-based subspace clustering for mining numerical data , 1999, KDD '99.
[31] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[32] Lisa A Carey,et al. Gene expression profiling in breast cancer , 2007, Current opinion in oncology.
[33] Philip M. Long,et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[34] Anant Madabhushi,et al. AUTOMATED GRADING OF PROSTATE CANCER USING ARCHITECTURAL AND TEXTURAL IMAGE FEATURES , 2007, 2007 4th IEEE International Symposium on Biomedical Imaging: From Nano to Macro.
[35] R. Salunga,et al. Gene expression profiles of human breast cancer progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[36] D. Vigushin,et al. Gene-expression profiling and identification of patients at high risk of breast cancer , 2002, The Lancet.
[37] S. Ménard,et al. Prognostic significance of her‐2/neu expression in breast cancer and its relationship to other prognostic factors , 1991, International journal of cancer.
[38] Ali S. Hadi,et al. Finding Groups in Data: An Introduction to Chster Analysis , 1991 .
[39] C. Sotiriou,et al. Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer , 2002, Breast Cancer Research.
[40] J. Anim,et al. Relationship between the expression of various markers and prognostic factors in breast cancer. , 2005, Acta histochemica.
[41] J. Foekens,et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.
[42] Robert Tibshirani,et al. Estimating the number of clusters in a data set via the gap statistic , 2000 .
[43] R. Dutton,et al. Type 1 and type 2 tumor infiltrating effector cell subpopulations in progressive breast cancer. , 2004, Clinical immunology.
[44] Sankar Ghosh,et al. NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[45] János Szöllosi,et al. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation. , 2005, Experimental cell research.
[46] M. Hussein,et al. Analysis of the mononuclear inflammatory cell infiltrate in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas: preliminary observations , 2006, Journal of Clinical Pathology.
[47] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[48] G. Bhanot,et al. Manifold learning with graph-based features for identifying extent of lymphocytic infiltration from high grade , HER 2 + breast cancer histology , 2008 .
[49] H. Fiegl,et al. The Expression of the Regulatory T Cell–Specific Forkhead Box Transcription Factor FoxP3 Is Associated with Poor Prognosis in Ovarian Cancer , 2005, Clinical Cancer Research.
[50] Gabriela Alexe,et al. High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates. , 2007, Cancer research.
[51] Joydeep Ghosh,et al. Cluster Ensembles A Knowledge Reuse Framework for Combining Partitionings , 2002, AAAI/IAAI.
[52] Purang Abolmaesumi,et al. Detection of Prostate Cancer from Whole-Mount Histology Images Using Markov Random Fields , 2008 .
[53] Anant Madabhushi,et al. A Boosting Cascade for Automated Detection of Prostate Cancer from Digitized Histology , 2006, MICCAI.
[54] Z. Trajanoski,et al. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.
[55] L. Egevad,et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma , 2005, The American journal of surgical pathology.
[56] J. Dering,et al. Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitro , 2007, Breast Cancer Research and Treatment.
[57] Teuvo Kohonen,et al. Self-Organizing Maps , 2010 .
[58] S. Ménard,et al. Pilot Study of the Mechanism of Action of Preoperative Trastuzumab in Patients with Primary Operable Breast Tumors Overexpressing HER2 , 2004, Clinical Cancer Research.
[59] Charles M Perou,et al. EGFR associated expression profiles vary with breast tumor subtype , 2007, BMC Genomics.
[60] Ferran Algaba,et al. Gleason grading of prostate cancer in needle biopsies or radical prostatectomy specimens: contemporary approach, current clinical significance and sources of pathology discrepancies , 2005, BJU international.
[61] Donald Geman,et al. Stochastic Relaxation, Gibbs Distributions, and the Bayesian Restoration of Images , 1984, IEEE Transactions on Pattern Analysis and Machine Intelligence.
[62] M. Cronin,et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.
[63] F. Bertucci,et al. Gene-expression profiling and identification of patients at high risk of breast cancer , 2002, The Lancet.
[64] Donald Geman,et al. Stochastic relaxation, Gibbs distributions, and the Bayesian restoration of images , 1984 .
[65] James Kelly,et al. AutoClass: A Bayesian Classification System , 1993, ML.
[66] Jill P. Mesirov,et al. Portraits of breast cancer progression , 2007, BMC Bioinformatics.
[67] Anant Madabhushi,et al. Automated grading of breast cancer histopathology using spectral clustering with textural and architectural image features , 2008, 2008 5th IEEE International Symposium on Biomedical Imaging: From Nano to Macro.
[68] Carsten O. Peterson,et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. , 2001, Cancer research.
[69] Joshy George,et al. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. , 2006, Cancer research.
[70] V. Beral. Breast cancer and hormone replacement therapy (HRT): collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer , 2002, Breast Cancer Research.
[71] D. Laune,et al. Oestrogen receptor negative breast cancers exhibit high cytokine content , 2007, Breast Cancer Research.
[72] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[73] Eric S. Lander,et al. Integrative Genomic Approaches Identify IKBKE as a Breast Cancer Oncogene , 2007, Cell.
[74] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[75] Michael J. Becich,et al. Tests for finding complex patterns of differential expression in cancers: towards individualized medicine , 2004, BMC Bioinformatics.
[76] T. Sørlie,et al. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms , 2006, BMC Genomics.
[77] J. Blay,et al. Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer , 2004, Clinical Cancer Research.
[78] L. Happerfield,et al. Angiogenesis and inflammation in ductal carcinoma in situ of the breast , 1997, The Journal of pathology.